ProtAb Company
ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways.
Technology:
Biologics (Ab)
Industry:
Geroscience
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
2005-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
3
Total Funding:
4000000
Estimated Revenue:
Less than $1M
Last Funding Date:
2010-04-23
Last Funding Type:
Series A
Register and Claim Ownership